scholarly journals Long-term effects of an occupational health guideline on employees’ body weight-related outcomes, cardiovascular disease risk factors, and quality of life: results from a randomized controlled trial

2013 ◽  
Vol 39 (3) ◽  
pp. 284-294 ◽  
Author(s):  
Lisanne M Verweij ◽  
Karin I Proper ◽  
Andre NH Weel ◽  
Carel TJ Hulshof ◽  
Willem van Mechelen
Keyword(s):  
Quality Of Life ◽  
Risk Factors ◽  
Disease Risk ◽  
Controlled Trial ◽  
Cardiovascular Disease Risk ◽  
Long Term Effects ◽  
Randomized Controlled ◽  
Health Guideline

scholarly journals Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial

2013 ◽  
Vol 76 (5) ◽  
pp. 668-679 ◽  
Author(s):  
Marije Russcher ◽  
Birgit C. P. Koch ◽  
J. Elsbeth Nagtegaal ◽  
Frans J. van Ittersum ◽  
Pieternel C. M. Pasker-de Jong ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Long Term Effects ◽  
Randomized Controlled

scholarly journals Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): Protocol for randomized controlled trial

2012 ◽  
Vol 17 (1) ◽  
pp. 17-28 ◽  
Author(s):  
Roberta K Oka ◽  
Michael S Conte ◽  
Christopher D Owens ◽  
Joseph Rapp ◽  
Gordon Fung ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Risk Factors ◽  
Controlled Trial ◽  
Cvd Risk Factors ◽  
Peripheral Artery ◽  
Cvd Risk ◽  
Randomized Controlled ◽  
Artery Disease

Peripheral artery disease (PAD) is an understudied chronic illness most prevalent in elderly individuals. PAD patients experience substantial walking impairment due to symptoms of limb ischemia that significantly diminishes quality of life (QOL). Cardiovascular disease (CVD) morbidity and mortality is increased in this population because of aggressive atherosclerosis resulting from untreated CVD risk factors. Despite current national guidelines recommending intensive CVD risk factor management for PAD patients, untreated CVD risk factors are common. Interventions that bridge this gap are imperative. The Vascular Insufficiency – Goals for Optimal Risk Reduction (VIGOR2) study is a randomized controlled trial (RCT) that examines the effectiveness of a long-term multifactor CVD risk reduction program on walking and quality of life in patients with PAD. The purpose of this article is to provide a detailed description of the design and methods of VIGOR2. Clinical Trial Registration – URL: http://clinicaltrials.gov/ct2/show/NCT00537225

Sign in / Sign up

Export Citation Format

Share Document